Venus Remedies Ltd Key Ratios

333.55
(-2.03%)
Dec 13, 2024|03:31:12 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

9.21

61.52

-8.88

-6.9

Op profit growth

15.5

31.74

3.4

-22.17

EBIT growth

-3.25

170.16

78.77

-38

Net profit growth

-34.06

-717.69

-67.42

79.68

Profitability ratios (%)

OPM

10.37

9.81

12.02

10.59

EBIT margin

6.16

6.95

4.15

2.11

Net profit margin

6.8

11.26

-2.94

-8.24

RoCE

7.59

7.5

2.26

1.12

RoNW

2.42

4.26

-0.72

-2.04

RoA

2.09

3.03

-0.4

-1.09

Per share ratios (₹)

EPS

30.47

50.04

-8.1

0

Dividend per share

0

0

0

0

Cash EPS

5.37

21.46

-34.03

-52.28

Book value per share

329.5

324.32

262

293.23

Valuation ratios

P/E

8.82

5.48

-2.77

0

P/CEPS

49.97

12.79

-0.66

-1.25

P/B

0.81

0.84

0.08

0.22

EV/EBIDTA

4.99

4.88

5.33

9.2

Payout (%)

Dividend payout

0

0

0

0

Tax payout

11.85

52.61

-252.87

11.47

Liquidity ratios

Debtor days

21.53

20.88

41.92

46.33

Inventory days

74.88

86.93

150.2

136.61

Creditor days

-41.73

-40.2

-40.81

-32.88

Leverage ratios

Interest coverage

-76.69

-2.92

-1.05

-0.22

Net debt / equity

-0.01

0.04

0.67

0.83

Net debt / op. profit

-0.12

0.37

5.34

7.67

Cost breakup (₹)

Material costs

-64.38

-62.17

-51.36

-55.06

Employee costs

-8.74

-8.39

-13.56

-10.55

Other costs

-16.49

-19.61

-23.04

-23.77

Venus Remedies : related Articles

Venus Remedies gets approval for pre-filled syringe facility
6 Nov 2024|10:36 AM

Furthermore, the NPRA's recognition will enable Venus Remedies to capitalise on the expanding global demand for enoxaparin.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp